These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21319156)
1. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Lima IS; Yasui Y; Scarfe A; Winget M Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Winget M; Hossain S; Yasui Y; Scarfe A Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180 [TBL] [Abstract][Full Text] [Related]
3. Survival and time interval from surgery to start of chemotherapy among colon cancer patients. Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115 [TBL] [Abstract][Full Text] [Related]
4. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
5. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Eldin NS; Yasui Y; Scarfe A; Winget M Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for stage III colon cancer: does timing matter? Czaykowski PM; Gill S; Kennecke HF; Gordon VL; Turner D Dis Colon Rectum; 2011 Sep; 54(9):1082-9. PubMed ID: 21825887 [TBL] [Abstract][Full Text] [Related]
7. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928 [TBL] [Abstract][Full Text] [Related]
8. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931 [TBL] [Abstract][Full Text] [Related]
10. Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada. Winget M; Fleming J; Li X; Gao Z; Butts C Lung Cancer; 2011 Apr; 72(1):52-8. PubMed ID: 20708293 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
12. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068 [TBL] [Abstract][Full Text] [Related]
14. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591 [TBL] [Abstract][Full Text] [Related]
15. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
16. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Gross CP; McAvay GJ; Guo Z; Tinetti ME Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973 [TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy for colon cancer]. Dahl O Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502 [TBL] [Abstract][Full Text] [Related]
19. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
20. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study. Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]